News

TAVR trial to assess alternative access sites


 

The alternative approaches also require additional equipment, and operators may be exposed to greater amounts of radiation. They may also lead to longer recovery and more incisional pain for patients, according to the societies.

Dr. Mack said that the trial will likely be completed in 6 months or less from its start date.

"Using registries for this kind of study has the potential to make new technology available in a timely manner while protecting patient safety," ACC Immediate Past President Dr. David Holmes said in a statement.

None of the physicians had relevant disclosures.

n.miller@elsevier.com

On Twitter @NaseemSMiller

Pages

Recommended Reading

Progress Limited in Transcatheter Repair of Mitral Regurgitation
MDedge Surgery
Bariatric surgery cut vascular events in diabetes
MDedge Surgery
Ruptured AAA triage to EVAR centers proposed
MDedge Surgery
FDA makes dabigatran contraindicated for mechanical valves
MDedge Surgery
Comprehensive mechanical circulatory support guidelines issued
MDedge Surgery
Postdischarge ED Visits Nearly as Frequent as Readmissions
MDedge Surgery
Minimally invasive surgery with sutureless valves shows benefits
MDedge Surgery
Anticoagulant dabigatran ups the required dose of heparin
MDedge Surgery
Pregnancy and Marfan: New insight into risks
MDedge Surgery
Hybrid CFV endovenectomy promising, but not for the faint at heart
MDedge Surgery

Related Articles